世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

医療用フッ素樹脂の市場規模、シェア、動向分析レポート:製品別(エチレンテトラフルオロエチレン、ポリテトラフルオロエチレン、ポリフッ化ビニリデン、フルオロエラストマー)、用途別、地域別、セグメント別予測、2022年~2030年


Medical Fluoropolymers Market Size, Share & Trends Analysis Report By Product (Ethylene Tetrafluoroethylene, Polytetrafluoroethylene, Polyvinylidene Fluoride, Fluoroelastomers), By Application, By Region, And Segment Forecasts, 2022 - 2030

医療用フッ素樹脂の市場成長とトレンド Grand View Research社の最新調査によると、医療用フッ素樹脂の世界市場規模は2030年までに9億6200万米ドルに達すると予測されています。同市場は2022年から2030年にか... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2022年7月18日 US$5,950
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
106 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

医療用フッ素樹脂の市場成長とトレンド

Grand View Research社の最新調査によると、医療用フッ素樹脂の世界市場規模は2030年までに9億6200万米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR9.2%で拡大すると予測されています。市場を牽引するのは、軽量で高強度のフッ素樹脂に対する需要の高まりです。この需要は、カテーテル、手術器具のハンドル、注射器などの医療機器に使用される高度なフッ素樹脂とその複合材料の開発に起因していると考えられます。

米国では、医療製品のコスト上昇とマージン縮小が頻繁に起こり、医療サービスプロバイダーや医療計画策定者に深刻な影響を与えています。このため、米国政府は、医療費負担適正化法(ACA)とメディケイドの導入により、医療費財源と保険制度の大幅な改革を実施することになりました。ACAやメディケイドなどの政府の主要な取り組みにより、米国では人口の多くが医療施設やサービスを利用できるようになりました。このため、米国ではブランド医薬品、医療機器、ヘルスケアサービスの需要が急増し、主に医療用部品、包装、創傷治療用途に使用される医療用フッ素樹脂の需要を牽引しています。

特に米国、中国、ドイツでは、消費者の医療費負担が増加しているため、この分野での需要が高まるものと思われます。さらに、世界中でポジティブコロナウィルスの発生が増加していることも、医療機器の需要に好影響を与え、医療用フッ素樹脂のニーズを高めています。医療行為における感染予防の強化や改善への取り組みが増加していることから、予測期間中、カテーテル、容器、注射器などの使い捨て製品の需要が高まると予想されます。その結果、医療用製品の製造に使用される繊維や樹脂、医療用エラストマー、生分解性フッ素樹脂は、予測期間中に需要が伸びると予想されます。

医療用ふっ素樹脂は、優れた引張強度を理由に工業用途で主に消費されており、今後も高い市場浸透率が続くと予想されます。インド、中国、中東の各政府による生産量増加のための支出増加が、近い将来、医療用フッ素樹脂市場の成長を促進すると予想されます。中国やインドの新興市場では、国内レベルでの医療費の増加に伴い、技術の進歩がPVDFとPTFEの需要を促進すると予想されます。その結果、医療用チューブ用途は近い将来、高い成長を遂げると予想されます。

医療用フッ素樹脂市場レポートハイライト

- 2021年の市場は北米が支配的であり、アジア太平洋地域は医療に対する消費者支出の増加により、予測期間中に収益面で最も速いCAGR 9.6%で拡大すると予想される

- 医療用部品は、カテーテル、容器、医療用バッグ、手術用器具、注射器の製造におけるフッ素樹脂の大量消費によって、2021年に最大のアプリケーションセグメントとなった

- 医療用部品におけるポリテトラフルオロエチレン(PTFE)の需要は、このフッ素樹脂の高い滅菌性や耐衝撃性などの優れた特性により、引き続き最も高くなると予想されます。さらに、人口の増加や慢性疾患の増加により、医療用材料への需要が高まると予想されます。

- 2021年2月、アルケマは常熟(中国)の生産施設に投資し、フッ素樹脂の生産能力を35%向上させました。この投資により、同社はフッ素樹脂の用途からさらなる旺盛な需要に後押しされるだろう



ページTOPに戻る


目次

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Scope And Assumptions
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Third-Party Perspective
1.3.5 Primary Research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation And Data Visualization
1.6 Data Validation And Publishing
1.7 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
2.2 Segmental Outlook
Chapter 3 Medical Fluoropolymers Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Global Fluoropolymers Market Outlook
3.2 Medical Fluoropolymers Market: Industry Value Chain Analysis
3.2.1 Raw Material Trends
3.2.1.1 Tetrafluoroethylene
3.2.1.2 Vinylidene Fluoride
3.2.1.3 Chlorotrifluoroethylene (CTFE)
3.3 Regulatory Framework
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Increase In Demand For Advanced Medical Technology And Devices
3.4.1.2 Growing Healthcare Investments In Emerging Economies
3.4.2 Market Restraint Analysis
3.4.2.1 Stringent Environmental Regulations
3.4.3 Market Opportunity Analysis
3.4.4 Market Challenge Analysis
3.4.4.1 Consumer Spending Capacity
3.4.4.2 Growing E-Waste
3.4.5 Porter’s Five Force Analysis
3.4.6 Pestel Analysis
Chapter 4 Medical Fluoropolymer Market: Product Estimates & Analysis
4.1 Product Movement Analysis & Market Share
4.2 Ethylene Tetrafluoroethylene (Etfe)
4.2.1 Medical Fluoropolymer Market Estimates And Forecasts, By Ethylene Tetrafluoroethylene, 2019 - 2030 (Kilotons) (USD Million)
4.3 Polytetrafluoroethylene (PTFE)
4.3.1 Medical Fluoropolymer Market Estimates And Forecasts, By Polytetrafluoroethylene, 2019 - 2030 (Kilotons) (USD Million)
4.4 Polyvinylidene Fluoride (Pvdf)
4.4.1 Medical Fluoropolymer Market Estimates And Forecasts, By Polyvinylidene Fluoride, 2019 - 2030 (Kilotons) (USD Million)
4.5 Fluoroelastomers
4.5.1 Medical Fluoropolymer Market Estimates And Forecasts, By Fluoroelastomers, 2019 - 2030 (Kilotons) (USD Million)
4.6 Others
4.6.1 Medical Fluoropolymer Market Estimates And Forecasts, By Others, 2019 - 2030 (Kilotons) (USD Million)
Chapter 5 Medical Fluoropolymer Market: Application Estimates & Analysis
5.1 Application Movement Analysis & Market Share
5.2 Medical Tubing
5.2.1 Medical Fluoropolymer Market Estimates And Forecasts, By Medical Tubing, 2019 - 2030 (Kilotons) (USD Million)
5.3 Catheters
5.3.1 Medical Fluoropolymer Market Estimates And Forecasts, By Catheters, 2019 - 2030 (Kilotons) (USD Million)
5.4 Medical Bags
5.4.1 Medical Fluoropolymer Market Estimates And Forecasts, By Medical Bags, 2019 - 2030 (Kilotons) (USD Million)
5.5 Drug Delivery Devices
5.5.1 Medical Fluoropolymer Market Estimates And Forecasts, By Drug Delivery Devices, 2019 - 2030 (Kilotons) (USD Million)
5.6 Others
5.6.1 Medical Fluoropolymer Market Estimates And Forecasts, By Others, 2019 - 2030 (Kilotons) (USD Million)
Chapter 6 Medical Fluoropolymers Market: Estimates & Trend Analysis
6.1 Medical Fluoropolymers Market: Regional Movement Analysis, 2021 & 2030
6.2 North America
6.2.1 North America Medical Fluoropolymers Market Estimates And Forecasts, 2019 - 2030 (Kilotons) (USD Million)
6.2.2 U.S.
6.2.3 Canada
6.2.4 Mexico
6.3 Europe
6.3.1 Europe Medical Fluoropolymers Market Estimates And Forecasts, 2019 - 2030 (Kilotons) (USD Million)
6.3.2 Germany
6.3.3 U.K.
6.3.4 France
6.3.5 Italy
6.4 Asia Pacific
6.4.1 Asia Pacific Medical Fluoropolymers Market Estimates And Forecasts, 2019 - 2030 (Kilotons) (USD Million)
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 South Korea
6.5 Central & South America
6.5.1 Central & South America Medical Fluoropolymers Market Estimates And Forecasts, 2019 - 2030 (Kilotons) (USD Million)
6.5.2 Brazil
6.6 Middle East & Africa
6.6.2 GCC Countries
Chapter 7 Competitive Landscape
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3 Vendor Landscape
7.3.1 List Of Key Distributors And Channel Partners
7.3.2 List Of Potential Customers
7.4 Public Companies
7.4.1 Competitive Dashboard Analysis
7.5 Private Companies
7.5.1 List Of Key Emerging Companies/Technology Disruptors/Innovators And Their Geographical Presence
Chapter 8 Company Profiles
8.1 Daikin Industries, Ltd.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiative
8.2 The Chemours Company
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiative
8.3 Solvay Sa
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiative
8.4 Arkema
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiative
8.5 Adtech Polymer Engineering Ltd.
8.5.1 Company Overview
8.5.2 Product Benchmarking
8.6 Dongyue Group Limited
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.7 Saint-Gobain
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.8 W. L. Gore & Associates, Inc.
8.8.1 Company Overview
8.8.2 Product Benchmarking
8.9 Hitachi, Ltd.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiative
8.10 Holscot Fluoropolymers Ltd.
8.10.1 Company Overview
8.10.2 Product Benchmarking

 

ページTOPに戻る


 

Summary

Medical Fluoropolymers Market Growth & Trends

The global medical fluoropolymers market size is expected to reach USD 962.0 million by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.2% from 2022 to 2030. The market is driven by the rising demand for lightweight and high-strength fluoropolymers. This demand can be attributed to the development of advanced fluoropolymers and their composites for use in medical devices such as catheters, surgical instrument handles, and syringes.

In the U.S., frequent increments in costs and reduced margins of medical products have severely impacted healthcare service providers and health plan formulators. This has led the Government of the U.S. to ensure a significant transformation in healthcare funding and insurance coverage in the country through the introduction of the Affordable Care Act (ACA) and Medicaid. Key government initiatives such as ACA and Medicaid have enabled a large percentage of the population of the U.S. to gain access to healthcare facilities and services. This has led to a surged demand for branded drugs, medical devices, and healthcare services in the country, thereby driving the demand for medical fluoropolymers in the U.S. primarily used in medical components, as well as packaging and wound care applications.

The rising level of consumer healthcare expenditure, notably in the United States, China, and Germany, is likely to boost the application segment. Furthermore, growing positive coronavirus incidences throughout the world are favorably affecting medical equipment demand, boosting the need for medical fluoropolymers. Increasing efforts to enforce and upgrade infection prevention during medical treatment are expected to drive the demand for disposable products such as catheters, containers, and syringes over the forecast period. As a result, fibers and resins, medical elastomers, and biodegradable fluoropolymers used for manufacturing medical products are expected to witness growth in demand over the forecast period.

Predominant consumption of medical fluoropolymers in industrial applications on account of good tensile strength is expected to keep its high market penetration. Rising expenditure by the governments of India, China, and the Middle East to enhance manufacturing output is expected to propel medical fluoropolymer market growth in the near future. Technological advancement in emerging markets of China and India in light of rising medical spending at the domestic level is expected to fuel the demand for PVDF and PTFE. As a result, medical tubing application is expected to witness high growth in the near future.

Medical Fluoropolymers Market Report Highlights

• North America dominated the market in 2021, while Asia Pacific is expected to expand at the fastest CAGR of 9.6% in terms of revenue over the forecast period on account of rising consumer expenditure on healthcare

• The medical component was the largest application segment in 2021, driven by the high-volume consumption of fluoropolymers in the manufacturing of catheters, containers, medical bags, surgical instruments, and syringes

• The demand for Polytetrafluoroethylene (PTFE) in medical components is expected to remain the highest due to the superior properties of this fluoropolymer such as high sterilization and impact resistance. Furthermore, the growing population coupled with the increasing prevalence of chronic diseases is likely to propel the demand for medical components

• In February 2021, Arkema has invested in its Changshu (China) production facility to increase its fluoropolymer production capacity by 35%. Owing to this investment, the company will be fueled by further strong demand for fluoropolymers from its applications



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Scope And Assumptions
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Third-Party Perspective
1.3.5 Primary Research
1.4 Information Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation And Data Visualization
1.6 Data Validation And Publishing
1.7 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
2.2 Segmental Outlook
Chapter 3 Medical Fluoropolymers Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Global Fluoropolymers Market Outlook
3.2 Medical Fluoropolymers Market: Industry Value Chain Analysis
3.2.1 Raw Material Trends
3.2.1.1 Tetrafluoroethylene
3.2.1.2 Vinylidene Fluoride
3.2.1.3 Chlorotrifluoroethylene (CTFE)
3.3 Regulatory Framework
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Increase In Demand For Advanced Medical Technology And Devices
3.4.1.2 Growing Healthcare Investments In Emerging Economies
3.4.2 Market Restraint Analysis
3.4.2.1 Stringent Environmental Regulations
3.4.3 Market Opportunity Analysis
3.4.4 Market Challenge Analysis
3.4.4.1 Consumer Spending Capacity
3.4.4.2 Growing E-Waste
3.4.5 Porter’s Five Force Analysis
3.4.6 Pestel Analysis
Chapter 4 Medical Fluoropolymer Market: Product Estimates & Analysis
4.1 Product Movement Analysis & Market Share
4.2 Ethylene Tetrafluoroethylene (Etfe)
4.2.1 Medical Fluoropolymer Market Estimates And Forecasts, By Ethylene Tetrafluoroethylene, 2019 - 2030 (Kilotons) (USD Million)
4.3 Polytetrafluoroethylene (PTFE)
4.3.1 Medical Fluoropolymer Market Estimates And Forecasts, By Polytetrafluoroethylene, 2019 - 2030 (Kilotons) (USD Million)
4.4 Polyvinylidene Fluoride (Pvdf)
4.4.1 Medical Fluoropolymer Market Estimates And Forecasts, By Polyvinylidene Fluoride, 2019 - 2030 (Kilotons) (USD Million)
4.5 Fluoroelastomers
4.5.1 Medical Fluoropolymer Market Estimates And Forecasts, By Fluoroelastomers, 2019 - 2030 (Kilotons) (USD Million)
4.6 Others
4.6.1 Medical Fluoropolymer Market Estimates And Forecasts, By Others, 2019 - 2030 (Kilotons) (USD Million)
Chapter 5 Medical Fluoropolymer Market: Application Estimates & Analysis
5.1 Application Movement Analysis & Market Share
5.2 Medical Tubing
5.2.1 Medical Fluoropolymer Market Estimates And Forecasts, By Medical Tubing, 2019 - 2030 (Kilotons) (USD Million)
5.3 Catheters
5.3.1 Medical Fluoropolymer Market Estimates And Forecasts, By Catheters, 2019 - 2030 (Kilotons) (USD Million)
5.4 Medical Bags
5.4.1 Medical Fluoropolymer Market Estimates And Forecasts, By Medical Bags, 2019 - 2030 (Kilotons) (USD Million)
5.5 Drug Delivery Devices
5.5.1 Medical Fluoropolymer Market Estimates And Forecasts, By Drug Delivery Devices, 2019 - 2030 (Kilotons) (USD Million)
5.6 Others
5.6.1 Medical Fluoropolymer Market Estimates And Forecasts, By Others, 2019 - 2030 (Kilotons) (USD Million)
Chapter 6 Medical Fluoropolymers Market: Estimates & Trend Analysis
6.1 Medical Fluoropolymers Market: Regional Movement Analysis, 2021 & 2030
6.2 North America
6.2.1 North America Medical Fluoropolymers Market Estimates And Forecasts, 2019 - 2030 (Kilotons) (USD Million)
6.2.2 U.S.
6.2.3 Canada
6.2.4 Mexico
6.3 Europe
6.3.1 Europe Medical Fluoropolymers Market Estimates And Forecasts, 2019 - 2030 (Kilotons) (USD Million)
6.3.2 Germany
6.3.3 U.K.
6.3.4 France
6.3.5 Italy
6.4 Asia Pacific
6.4.1 Asia Pacific Medical Fluoropolymers Market Estimates And Forecasts, 2019 - 2030 (Kilotons) (USD Million)
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 South Korea
6.5 Central & South America
6.5.1 Central & South America Medical Fluoropolymers Market Estimates And Forecasts, 2019 - 2030 (Kilotons) (USD Million)
6.5.2 Brazil
6.6 Middle East & Africa
6.6.2 GCC Countries
Chapter 7 Competitive Landscape
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
7.3 Vendor Landscape
7.3.1 List Of Key Distributors And Channel Partners
7.3.2 List Of Potential Customers
7.4 Public Companies
7.4.1 Competitive Dashboard Analysis
7.5 Private Companies
7.5.1 List Of Key Emerging Companies/Technology Disruptors/Innovators And Their Geographical Presence
Chapter 8 Company Profiles
8.1 Daikin Industries, Ltd.
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Product Benchmarking
8.1.4 Strategic Initiative
8.2 The Chemours Company
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Product Benchmarking
8.2.4 Strategic Initiative
8.3 Solvay Sa
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Product Benchmarking
8.3.4 Strategic Initiative
8.4 Arkema
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Product Benchmarking
8.4.4 Strategic Initiative
8.5 Adtech Polymer Engineering Ltd.
8.5.1 Company Overview
8.5.2 Product Benchmarking
8.6 Dongyue Group Limited
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Product Benchmarking
8.7 Saint-Gobain
8.7.1 Company Overview
8.7.2 Financial Performance
8.7.3 Product Benchmarking
8.8 W. L. Gore & Associates, Inc.
8.8.1 Company Overview
8.8.2 Product Benchmarking
8.9 Hitachi, Ltd.
8.9.1 Company Overview
8.9.2 Financial Performance
8.9.3 Product Benchmarking
8.9.4 Strategic Initiative
8.10 Holscot Fluoropolymers Ltd.
8.10.1 Company Overview
8.10.2 Product Benchmarking

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/10/04 10:27

147.72 円

163.39 円

196.69 円

ページTOPに戻る